January 3, 2012 by admin
The day-to-day operation of the National Reporting and Learning System, said to be the largest source of patient safety incident data in the world, looks set to transfer to Imperial College Healthcare NHS Trust for a period of two years (see here). The National Patient Safety Agency is being abolished and its patient safety function will go to the new NHS Commissioning Board, which will provide oversight of the NRLS.
November 10, 2010 by admin
A ‘traffic light’ system which categorises - as red, orange and green - potential risks as consequences of delayed or omitted medicines in hospitals, for different drugs or drug classes from the BNF, has been developed by the UKMi and can be found here. The National Patient Safety Agency (NPSA) published a Rapid Response Report earlier this year on reducing harm from omitted and delayed medicines in hospital which said that organisations need to construct a list of medicines for which timeliness is crucial as well, among the other actions necessary. This tool is designed to help in drawing up local lists, not to replace them, as well as help with the other actions identified.
August 4, 2010 by admin
The government is planning to abolish the National Patient Safety Agency (NPSA), according to plans it has set out in its review of arm’s-length bodies (see here).
Its functions will be divided among different bodies, with the work related to reporting and learning from serious patient safety incidents moving to the new NHS Commissioning Board, and the National Research Ethics Service being considered as part of a review of research regulation. The Health Protection Agency and National Treatment Agency for Substance Misuse are also to be abolished, with their functions transferring to the new public health service.
Matt Griffiths, ANP committee member and visiting professor of prescribing and medicines management at the University of the West of England, is concerned about these plans: “Medication safety is a huge, huge issue and should be high-profile - it needs to be considered as a whole. Enforcement and policy making should be informed by research, and it is vital that the expertise is on board to reduce the large number of medication-related hospital admissions and incidents each year”.
June 25, 2010 by admin
The National Patient Safety Agency (NPSA) has issued guidance that aims to reduce the number of insulin-related wrong dose incidents. It applies to all English and Welsh NHS organizations. Two common errors that the guidance seeks to address are: the inappropriate use of non-insulin syringes, which are marked in ml not insulin units; and the use of abbreviations such as ‘U’ or ‘IU’ for units which can lead to doses being misread (eg, 10U being read as 100).